TECTONIC THERAPEUTIC, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent
TECTONIC THERAPEUTIC, INC. (TECX) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent of 1.90% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch · last filed 2026-02-26
- TECTONIC THERAPEUTIC, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2025 was 1.90%, a 13.64% decline from fiscal 2024.
- TECTONIC THERAPEUTIC, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2024 was 2.20%.
- TECTONIC THERAPEUTIC, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2023 was -4.30%, a 637.50% decline from fiscal 2022.
- TECTONIC THERAPEUTIC, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2022 was 0.80%, a 60.00% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 1.90% 10-K · filed 2026-02-26 | |
| 2024-12-31 | 2.20% 10-K · filed 2026-02-26 | |
| 2023-12-31 | -4.30% 10-K · filed 2024-03-14 | |
| 2022-12-31 | 0.80% 10-K · filed 2024-03-14 | |
| 2021-12-31 | 2.00% 10-K · filed 2023-03-23 | |
| 2020-12-31 | 2.30% 10-K · filed 2022-03-17 | |
| 2019-12-31 | 2.10% 10-K · filed 2021-03-18 | |
| 2018-12-31 | 1.10% 10-K · filed 2020-03-16 | -1.10% 10-K · filed 2019-03-25 |
| 2017-12-31 | -1.30% 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |